Acute lymphocytic leukemia (ALL) is a type of blood cancer.
急性淋巴细胞性白血病(all)是血癌的一种。
Methods The experience from 21 cases of children with acute lymphocytic leukemia was summarized.
方法回顾性总结21例急性淋巴细胞白血病患儿化疗的护理经验。
JM is a acute lymphocytic leukemia cell line derived from immature t lymphocytes in human thymus.
JM是来自人胸腺不成熟t细胞的急性淋巴细胞白血病细胞系。
Acute lymphocytic leukemia is also known as acute lymphoblastic leukemia and acute childhood leukemia.
急性淋巴细胞性白血病也称急性淋巴母细胞性白血病，又称急性儿童期白血病。
In acute lymphocytic leukemia, bone pain occurs in approximately 25% of patients at the onset of the disease.
急性淋巴细胞白血病患者中，大概只有25%的人在初期会感受到骨骼处产生的疼痛。
The "lymphocytic" in acute lymphocytic leukemia refers to the white blood cells called lymphocytes, which ALL affects.
“淋巴细胞性”是指患有ALL后，淋巴细胞发生了癌变，而淋巴细胞是白细胞的一种。
Acute lymphocytic leukemia is the most common type of cancer in children, and treatments result in a good chance for a cure.
急性淋巴细胞性白血病是儿童最为常见的癌症，而且治疗能带来疾病治愈的好机会(译者：指治愈希望较大)。
Acute lymphocytic leukemia and acute myelogenous leukemia are each composed of blast cells, known as lymphoblasts or myeloblasts.
急性淋巴细胞白血病和急性粒细胞性白血病均由癌变的母细胞引起，如淋巴母细胞或原始粒细胞。
Acute lymphocytic leukemia (ALL) is a type of cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made.
急性淋巴细胞性白血病(all)是一种发生于血液和骨髓的癌症——骨髓(译者：此处指红骨髓)是指作为造血场所的骨内的海绵组织。
In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.
在急性髓细胞性白血病aml和急性淋巴细胞性白血病all中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。
Recently, elevated IL-18 levels were found in serum from some leukemia patients, especially those with acute lymphocytic leukemia (all) and chronic myeloid leukemia (CML).
近来，研究发现急性淋巴细胞白血病(all)和慢性粒细胞白血病(CML)患者血清中il - 18水平高于正常人。
METHODS: a total of 25 patients with acute leukemia received HLA-identical sibling allo-PBSCT. All cases included 20 cases with acute myeloid leukemia and 5 cases with acute lymphocytic leukemia.
方法：25例急性白血病患者接受HLA相合同胞的异基因外周血造血干细胞移植，其中急性髓系白血病20例，急性淋巴细胞白血病5例。
Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
相对于急性白血病，慢性淋巴细胞白血病和慢性粒细胞性白血病通常进展缓慢。
In high concentrations, preparations have shown to inhibit cells from acute lymphocytic and acute granulocytic leukemia.
在高浓度，筹备工作已经表明，以抑制急性淋巴细胞白血病和急性粒细胞白血病细胞。
"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
Objective: to investigated the therapy effect and prognosis related factors in the Acute Non-lymphocytic leukemia (ANLL) patients.
目的：探讨我院急性非淋巴细胞性白血病(ANLL)患者的治疗效果及其预后相关因素。
The plasma concentration of thrombomodulin (TM) were measured in 29 cases of acute non-lymphocytic leukemia (ANLL). Plasma TM level significantly increased in ANLL patients.
本文对29例急性非淋巴细胞白血病(ANLL)患者的血浆血栓调节蛋白(TM)水平进行检测，发现ANLL组血浆TM水平比正常组明显升高。
The plasma concentration of thrombomodulin (TM) were measured in 29 cases of acute non-lymphocytic leukemia (ANLL). Plasma TM level significantly increased in ANLL patients.
本文对29例急性非淋巴细胞白血病(ANLL)患者的血浆血栓调节蛋白(TM)水平进行检测，发现ANLL组血浆TM水平比正常组明显升高。
应用推荐